Staining characteristics of p16INK4a: Is there a correlation with lesion grade or high-risk human papilloma virus positivity?

Journal of Obstetrics and Gynaecology Research

Volumn 34, Issue 5, 2008, Pages 865-871

  Ozgul, Nejat ^b   Cil, Aylin P ^a,c   Bozdayi, Gulendam ^d   Usubutun, Alp ^e   Bulbul, Dilek ^b   Rota, Seyyar ^d   Kose, M Faruk ^b   Biri, Aydan ^d   Haberal, Ali ^b  

^a Division of Gynecologic Oncology ^*  (Turkey)

^b Etlik Maternity and Women's Health Teaching Hospital   (Turkey)

^c KIRIKKALE UNIVERSITY   (Turkey)

^d GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^e HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; High grade squamous intraepithelial lesion; Immunohistochemistry; Low grade squamous intraepithelial lesion; p16

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; STAINING AND LABELING; UTERINE CERVICAL NEOPLASMS;

EID: 52049089689     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00795.x     Document Type: Article

References (19)

1. Nieminen P, Kallio M, Anttila A, Hakama M. Organized vs spontaneous pap-smear screening for cervical cancer: A case control study. Int J Cancer 1999 83 : 55 58.
2. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001 37 (Suppl 8 4 66.
3. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001 285 : 1500 1505.
4. Wright TC Jr., Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000 283 : 81 86.
5. Tsuda H, Hashiguchi Y, Nishimura S, Kawamura N, Inoue T, Yamamoto K. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm. Gynecol Oncol 2003 91 : 476 485.
6. Klaes R, Friedrich T, Spitkovsky D et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001 92 : 276 284.
7. Murphy N, Ring M, Killalea AG et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep TM smears. J Clin Pathol 2003 56 : 56 63.
8. Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol 2001 8 : 83 92.
9. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papilloma virus oncogenic potential in cervical and genital lesions. Am J Pathol 1998 153 : 1741 1748.
10. Nakao Y, Yang X, Yokoyama M et al. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer 1997 75 : 1410 1416.
11. Keating JT, Cviko A, Riethdorf S et al. Ki-67, cyclin E, and p16INK4a are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001 25 : 884 891.
12. Dray M, Russell P, Dalrymple C et al. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005 37 : 112 124.
13. Mahmud SM, Franco EL. An overview of epidemiological and public health research on HPVs presented at the 21st International Papillomavirus Conference in Mexico City, 20-26 February 2004. Papilloma virus Rep 2004 15 : 121 123.
14. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Sh KV. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 189 : 12 19.
15. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16(INK4a) expression correlates with degree of cervical neoplasia: A comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003 16 : 665 673.
16. Branca M, Ciotti M, Santini D et al. p16(INK4A) expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 2004 23 : 354 365.
17. Murphy N, Ring M, Heffron CC et al. P16INK4a, CDC6, and MCM5: Predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005 58 : 525 534.
18. Benevolo M, Mottolese M, Marandino F et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006 19 : 384 391.
19. Lambert AP, Anschau F, Schmitt VM. p16INK4a expression in cervical premalignant and malignant lesions. Exp Mol Pathol 2006 80 : 192 196.